Lisette M. Acevedo, Ph.D. - Publications

Affiliations: 
2004 Yale University, New Haven, CT 
Area:
Pharmacology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Acevedo LM, Lindquist JN, Walsh BM, Sia P, Cimadamore F, Chen C, Denzel M, Pernia CD, Ranscht B, Terskikh A, Snyder EY, Cheresh DA. hESC Differentiation toward an Autonomic Neuronal Cell Fate Depends on Distinct Cues from the Co-Patterning Vasculature. Stem Cell Reports. 4: 1075-88. PMID 26004631 DOI: 10.1016/J.Stemcr.2015.04.013  0.393
2014 Song RS, Carroll JM, Acevedo L, Wu D, Liu Y, Snyder EY. Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns. Current Protocols in Stem Cell Biology. 29: 1C.16.1-1C.16.13. PMID 24838913 DOI: 10.1002/9780470151808.Sc01C16S29  0.304
2012 Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD. VEGF-induced vascular permeability is mediated by FAK. Developmental Cell. 22: 146-57. PMID 22264731 DOI: 10.1016/J.Devcel.2011.11.002  0.541
2011 Acevedo LM, Desgrosellier J, Cheresh DA. Abstract 1474: Semaphorin 3A potentiates metastatic disease by binding to endothelial Neuropilin-1 and disrupting vascular barrier function Cancer Research. 71: 1474-1474. DOI: 10.1158/1538-7445.Am2011-1474  0.454
2010 Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16: 909-14. PMID 20676106 DOI: 10.1038/Nm.2186  0.3
2010 Murphy EA, Shields DJ, Stoletov K, Dneprovskaia E, McElroy M, Greenberg JI, Lindquist J, Acevedo LM, Anand S, Majeti BK, Tsigelny I, Saldanha A, Walsh B, Hoffman RM, Bouvet M, et al. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proceedings of the National Academy of Sciences of the United States of America. 107: 4299-304. PMID 20154271 DOI: 10.1073/Pnas.0909299107  0.369
2010 Nam J, Acevedo LM, Goka E, Chen XL, Walsh C, Tanjoni I, Guan J, Weis SM, Cheresh DA, Schlaepfer DD. Abstract 389: Mice with kinase-dead FAK mutation in endothelial cells are protected from VEGF-induced permeability and are resistant to tumor cell metastasis Cancer Research. 70: 389-389. DOI: 10.1158/1538-7445.Am10-389  0.427
2008 Acevedo LM, Cheresh DA. Suppressing NFAT increases VEGF signaling in hemangiomas. Cancer Cell. 14: 429-30. PMID 19061833 DOI: 10.1016/J.Ccr.2008.11.009  0.461
2008 Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature. 456: 809-13. PMID 18997771 DOI: 10.1038/Nature07424  0.542
2008 Acevedo LM, Weis SM, Cheresh DA. Robo4 counteracts VEGF signaling. Nature Medicine. 14: 372-3. PMID 18391935 DOI: 10.1038/Nm0408-372  0.498
2008 Schleicher M, Shepherd BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, Acevedo LM, Shadel GS, Sessa WC. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. The Journal of Cell Biology. 180: 101-12. PMID 18195103 DOI: 10.1083/Jcb.200706072  0.601
2008 Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood. 111: 2674-80. PMID 18180379 DOI: 10.1182/Blood-2007-08-110205  0.521
2007 Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P, Sessa WC. Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. The Journal of Biological Chemistry. 282: 30745-53. PMID 17702744 DOI: 10.1074/Jbc.M704798200  0.665
2007 Alavi AS, Acevedo L, Min W, Cheresh DA. Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1. Cancer Research. 67: 2766-72. PMID 17363598 DOI: 10.1158/0008-5472.Can-06-3648  0.487
2006 Miao RQ, Gao Y, Harrison KD, Prendergast J, Acevedo LM, Yu J, Hu F, Strittmatter SM, Sessa WC. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 10997-1002. PMID 16835300 DOI: 10.1073/Pnas.0602427103  0.632
2004 Fulton D, Babbitt R, Zoellner S, Fontana J, Acevedo L, McCabe TJ, Iwakiri Y, Sessa WC. Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release. The Journal of Biological Chemistry. 279: 30349-57. PMID 15136572 DOI: 10.1074/Jbc.M402155200  0.624
2004 Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, Fulton D, Tempst P, Strittmatter SM, Sessa WC. A new role for Nogo as a regulator of vascular remodeling. Nature Medicine. 10: 382-8. PMID 15034570 DOI: 10.1038/Nm1020  0.629
2000 Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nature Medicine. 6: 1362-7. PMID 11100121 DOI: 10.1038/82176  0.655
Show low-probability matches.